Tactile Systems Technology (NASDAQ:TCMD) Issues Quarterly Earnings Results

Tactile Systems Technology (NASDAQ:TCMD) announced its quarterly earnings data on Monday. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.20, Zacks reports. Tactile Systems Technology had a return on equity of 7.72% and a net margin of 5.06%. Tactile Systems Technology updated its FY 2025 guidance to EPS.

Tactile Systems Technology Price Performance

Shares of NASDAQ:TCMD opened at $15.77 on Tuesday. Tactile Systems Technology has a fifty-two week low of $8.61 and a fifty-two week high of $21.10. The company’s 50-day moving average is $14.18 and its 200 day moving average is $12.09. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.36 and a current ratio of 3.79. The company has a market capitalization of $351.54 million, a P/E ratio of 25.44 and a beta of 1.04.

Insider Buying and Selling at Tactile Systems Technology

In other news, CEO Sheri Louise Dodd sold 7,762 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $12.36, for a total transaction of $95,938.32. Following the completion of the sale, the chief executive officer owned 173,479 shares in the company, valued at $2,144,200.44. This trade represents a 4.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tactile Systems Technology

Several institutional investors and hedge funds have recently bought and sold shares of the company. Oxford Asset Management LLP bought a new stake in shares of Tactile Systems Technology in the second quarter valued at $124,000. Cresset Asset Management LLC lifted its holdings in Tactile Systems Technology by 14.3% during the second quarter. Cresset Asset Management LLC now owns 22,894 shares of the company’s stock valued at $232,000 after purchasing an additional 2,858 shares during the last quarter. Prudential Financial Inc. boosted its position in Tactile Systems Technology by 3.5% during the second quarter. Prudential Financial Inc. now owns 24,360 shares of the company’s stock worth $247,000 after purchasing an additional 835 shares during the period. Bridgeway Capital Management LLC purchased a new position in shares of Tactile Systems Technology in the second quarter worth about $342,000. Finally, Rhumbline Advisers raised its position in shares of Tactile Systems Technology by 4.0% in the second quarter. Rhumbline Advisers now owns 37,780 shares of the company’s stock valued at $383,000 after purchasing an additional 1,441 shares during the period. 83.43% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

TCMD has been the subject of several research reports. Wall Street Zen raised shares of Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a research report on Saturday. William Blair upgraded shares of Tactile Systems Technology to a “strong-buy” rating in a report on Tuesday, August 5th. Lake Street Capital started coverage on shares of Tactile Systems Technology in a research report on Friday, October 3rd. They issued a “buy” rating and a $23.50 price target on the stock. B. Riley reissued a “neutral” rating and set a $13.00 price objective (up from $12.00) on shares of Tactile Systems Technology in a report on Tuesday, August 5th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Tactile Systems Technology in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Tactile Systems Technology has a consensus rating of “Hold” and an average price target of $16.83.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.